These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 26156206)
1. Sacral neuromodulation: an effective treatment for lower urinary tract symptoms in multiple sclerosis. Puccini F; Bhide A; Elneil S; Digesu GA Int Urogynecol J; 2016 Mar; 27(3):347-54. PubMed ID: 26156206 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of the implantable, magnetic resonance imaging-compatible StimRouter neuromodulation system in the treatment of refractory lower urinary tract symptoms in multiple sclerosis patients. Sacco R; Maino P; Koetsier E; Disanto G; Renard J; Digesu A; Gobbi C; Zecca C Eur J Neurol; 2024 Feb; 31(2):e16146. PubMed ID: 37975785 [TBL] [Abstract][Full Text] [Related]
3. Sacral neuromodulation in patients with multiple sclerosis. Minardi D; Muzzonigro G World J Urol; 2012 Feb; 30(1):123-8. PubMed ID: 21400258 [TBL] [Abstract][Full Text] [Related]
4. Posterior tibial nerve stimulation in the management of lower urinary tract symptoms in patients with multiple sclerosis. Zecca C; Panicari L; Disanto G; Maino P; Singh A; Digesu GA; Gobbi C Int Urogynecol J; 2016 Apr; 27(4):521-7. PubMed ID: 26245726 [TBL] [Abstract][Full Text] [Related]
5. Which clinical risk factors determine a pathological urodynamic evaluation in patients with multiple sclerosis? an analysis of 100 prospective cases. Wiedemann A; Kaeder M; Greulich W; Lax H; Priebel J; Kirschner-Hermanns R; Füsgen I World J Urol; 2013 Feb; 31(1):229-33. PubMed ID: 22227822 [TBL] [Abstract][Full Text] [Related]
6. [Sacral neuromodulation as second-line treatment strategy for lower urinary tract symptoms of various aetiologies: experience of a German high-volume clinic]. Otto W; Nowrotek A; Burger M; Wieland WF; Rößler W; Denzinger S Aktuelle Urol; 2012 May; 43(3):162-6. PubMed ID: 22639025 [TBL] [Abstract][Full Text] [Related]
7. Systematic Literature Review and Meta-Analysis of Sacral Neuromodulation (SNM) in Patients with Neurogenic Lower Urinary Tract Dysfunction (nLUTD): Over 20 Years' Experience and Future Directions. van Ophoven A; Engelberg S; Lilley H; Sievert KD Adv Ther; 2021 Apr; 38(4):1987-2006. PubMed ID: 33713279 [TBL] [Abstract][Full Text] [Related]
8. Cortical, Spinal, Sacral, and Peripheral Neuromodulations as Therapeutic Approaches for the Treatment of Lower Urinary Tract Symptoms in Multiple Sclerosis Patients: A Review. Pericolini M; Miget G; Hentzen C; Finazzi Agrò E; Chesnel C; Lagnau P; Haddad R; Grasland M; Amarenco G Neuromodulation; 2022 Dec; 25(8):1065-1075. PubMed ID: 34496454 [TBL] [Abstract][Full Text] [Related]
9. Usefulness of sacral nerve modulation in a series of multiple sclerosis patients with bladder dysfunction. Andretta E; Simeone C; Ostardo E; Pastorello M; Zuliani C J Neurol Sci; 2014 Dec; 347(1-2):257-61. PubMed ID: 25454644 [TBL] [Abstract][Full Text] [Related]
11. Maintenance percutaneous posterior nerve stimulation for refractory lower urinary tract symptoms in patients with multiple sclerosis: an open label, multicenter, prospective study. Zecca C; Digesu GA; Robshaw P; Singh A; Elneil S; Gobbi C J Urol; 2014 Mar; 191(3):697-702. PubMed ID: 24076308 [TBL] [Abstract][Full Text] [Related]
12. Percutaneous posterior tibial nerve stimulation (PTNS) for lower urinary tract symptoms (LUTSs) treatment in patients with multiple sclerosis (MS): A systematic review and meta-analysis. Guitynavard F; Mirmosayyeb O; Razavi ERV; Hosseini M; Hosseinabadi AM; Ghajarzadeh M; Azadvari M Mult Scler Relat Disord; 2022 Feb; 58():103392. PubMed ID: 35216773 [TBL] [Abstract][Full Text] [Related]
13. Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series. Engeler DS; Meyer D; Abt D; Müller S; Schmid HP BMC Urol; 2015 Oct; 15():105. PubMed ID: 26498275 [TBL] [Abstract][Full Text] [Related]
14. A prospective observational cohort study of posterior tibial nerve stimulation in patients with multiple sclerosis: design and methods. Lane GI; Mao-Draayer Y; Barboglio-Romo P; Clemens JQ; Gupta P; Dunn R; Qin Y; Cameron AP; Stoffel JT BMC Urol; 2020 May; 20(1):58. PubMed ID: 32460741 [TBL] [Abstract][Full Text] [Related]
16. The diagnosis and management of lower urinary tract symptoms in multiple sclerosis patients. Sand PK; Sand RI Dis Mon; 2013 Jul; 59(7):261-8. PubMed ID: 23786660 [TBL] [Abstract][Full Text] [Related]
17. Neuromodulation for the Treatment of Lower Urinary Tract Symptoms. Yamanishi T; Kaga K; Fuse M; Shibata C; Uchiyama T Low Urin Tract Symptoms; 2015 Sep; 7(3):121-32. PubMed ID: 26663726 [TBL] [Abstract][Full Text] [Related]
18. Neuromodulation for lower urinary tract symptoms in special populations. Wang CN; Chung DE Neurourol Urodyn; 2022 Nov; 41(8):1948-1957. PubMed ID: 35579275 [TBL] [Abstract][Full Text] [Related]
19. Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosis. Osman NI; Chapple CR; Abrams P; Dmochowski R; Haab F; Nitti V; Koelbl H; van Kerrebroeck P; Wein AJ Eur Urol; 2014 Feb; 65(2):389-98. PubMed ID: 24184024 [TBL] [Abstract][Full Text] [Related]
20. Management of lower urinary tract dysfunction in multiple sclerosis: a systematic review and Turkish consensus report. Çetinel B; Tarcan T; Demirkesen O; Özyurt C; Şen İ; Erdoğan S; Siva A Neurourol Urodyn; 2013 Nov; 32(8):1047-57. PubMed ID: 23757108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]